T-cell Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for T-cell Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) [Phase 1, Phase 2]
This update describes BEAM-201, a study in relapsed/refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma, in Pha…
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: VHAG in Treating R/R T-ALL/LBL [Phase 2]
Phase 2 clinical trial evaluating VHAG for relapsed/refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma, curren…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating sequential CD5/CD7-specific CAR-T cells for CD5/CD7-positive T-cell malignancies including T-…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients [Phase 3]
This is a Phase 3 clinical trial comparing Busulfan-Cyclophosphamide (BuCy) versus Total Body Irradiation-Cyclophosphamide (TBICy) condition…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL [EARLY_Phase 1]
The entry reports an early-phase 1 clinical trial evaluating CD5-targeted CAR-T cells for relapsed/refractory CD5-positive T-cell acute lymp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma. [Phase 2]
A Phase 2 clinical trial evaluating BCL-2 inhibitors in combination with the HyperCVAD regimen for newly diagnosed T-cell lymphoblastic leuk…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients [Phase 3]
A Phase 3 trial compares haplo-cord hematopoietic stem cell transplantation with haploidentical HCT in patients with T-cell acute lymphoblas…
-
CLINICAL_TRIALS research · 2018-06-21Clinical Trial Update: Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL [Phase 2, Phase 3]
Clinical trial update for chidamide-based targeted therapy in adult T-cell lymphoblastic leukemia/lymphoma (T-LBL/ALL), spanning Phase 2 and…
-
CLINICAL_TRIALS research · 2018-06-12Clinical Trial Update: Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL [Phase 2, Phase 3]
A Phase 2/3 clinical trial update evaluating chidamide, an HDAC inhibitor, as targeted therapy for adult early T-cell precursor acute lympho…
-
CLINICAL_TRIALS research · 2016-07-11Clinical Trial Update: Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
A completed study analyzing gene expression in samples from patients with T-cell acute lymphoblastic leukemia, sponsored by the Children's O…
-
CLINICAL_TRIALS research · 2016-05-18Clinical Trial Update: Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
An update on a biomarker study analyzing bone marrow samples from patients with T-cell acute lymphoblastic leukemia.
-
CLINICAL_TRIALS research · 2016-05-17Clinical Trial Update: Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia
This clinical trial update describes RNA studies using samples from younger patients with T-cell acute lymphoblastic leukemia.
-
CLINICAL_TRIALS research · 2015-05-27Clinical Trial Update: A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013) [Phase 1]
Phase 1 trial of a Notch signaling pathway inhibitor (MK-0752) in T-cell acute lymphoblastic leukemia/lymphoma has been terminated.
-
CLINICAL_TRIALS research · 2012-10-24Clinical Trial Update: Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma. [Phase 1, Phase 2]
Terminated Phase 1/2 pharmacokinetic study of forodesine in children with relapsed or refractory T-cell or B-cell precursor acute lymphoblas…